Some in vivo effects of chelation. I. Rheumatoid arthritis.
暂无分享,去创建一个
[1] A. Boyle,et al. Effect of Chelation on Phosphorus Metabolism in Experimental Atherosclerosis , 1962, Circulation research.
[2] R. Mosher,et al. Chelation therapy in circulatory and sclerosing diseases. , 1961, Federation proceedings.
[3] Hardy Hl. Clinical experience with the use of calcium disodium ethylenediaminetetraacetate in the therapy of lead poisoning. , 1961 .
[4] R. Mosher,et al. The Influence of Experimentally Induced Atherosclerosis on the Sulfate Content of the Aortic Wall , 1960, Circulation research.
[5] R. Winkelmann,et al. The treatment of scleroderma with the new chelating agent, edathamil. , 1959, A.M.A. archives of dermatology.
[6] J. M. Price,et al. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA). , 1957, The Journal of investigative dermatology.
[7] J. M. Price,et al. Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA). , 1957, The Journal of investigative dermatology.
[8] R. Peñalver. Diagnosis and treatment of manganese intoxication; report of a case. , 1957, A.M.A. archives of industrial health.
[9] R. A. Vogel,et al. Spontaneous Microsporum audouinii infection in a guinea pig. , 1957, The Journal of investigative dermatology.
[10] M. Stephens,et al. Clinical and Serological Evaluation of 6162 Comparative Slide Tests with Cardiolipin, Natural Lecithin Antigen and Cardiolipin, Synthetic Lecithin Antigen1 , 1957 .
[11] M. Rubin,et al. Effect of Calcium Disodium Ethylenediamine Tetraacetate on Hypercholesterolemia Rabbits , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[12] R. Klein,et al. Treatment of scleroderma, sclerodactylia and calcinosis by chelation (EDTA). , 1955, The American journal of medicine.
[13] Kosal Mf,et al. Ethylenediaminetetraacetic acid in manganese poisoning of rats; a preliminary study. , 1956 .